000 01265 a2200373 4500
005 20250516121521.0
264 0 _c20130806
008 201308s 0 0 eng d
022 _a1423-0313
024 7 _a10.1159/000343243
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBauer, M
245 0 0 _aPharmacokinetics of single ascending doses of the P-glycoprotein inhibitor tariquidar in healthy subjects.
_h[electronic resource]
260 _bPharmacology
_c2013
300 _a12-9 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aATP Binding Cassette Transporter, Subfamily B, Member 1
_xantagonists & inhibitors
650 0 4 _aAdministration, Intravenous
650 0 4 _aAdult
650 0 4 _aArea Under Curve
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aQuinolines
_xadverse effects
650 0 4 _aYoung Adult
700 1 _aZeitlinger, M
700 1 _aTodorut, D
700 1 _aBöhmdorfer, M
700 1 _aMüller, M
700 1 _aLanger, O
700 1 _aJäger, W
773 0 _tPharmacology
_gvol. 91
_gno. 1-2
_gp. 12-9
856 4 0 _uhttps://doi.org/10.1159/000343243
_zAvailable from publisher's website
999 _c22259141
_d22259141